Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-AG-ZEBOV-GP in a sub-Saharan African paediatric population: A randomised controlled, open-label trial in children aged 1-12 years living in Lambaréné, Gabon

Alabi, Ayodele; Kokou, Kossiwa; Mahmoudou, Saidou; Kavishna, Ranmali; Nakka, Sravya S.; Rothenberger, Sylvia; Musangomunei, Fungai P.; Olubiyi, Bisola F.; Bie-Ondo, Juste C.; Kabwende, Anita L.; Velavan, Thirumalaisamy P.; Medaglini, Donata; Nakaya, Helder I.; Engler, Olivier; Harandi, Ali M.; Siegrist, Claire-Anne; Kremsner, Peter G.; Agnandji, Selidji T.

Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-AG-ZEBOV-GP in a sub-Saharan African paediatric population: A randomised controlled, open-label trial in children aged 1-12 years living in Lambaréné, Gabon

Autor(en):

Alabi, Ayodele; Kokou, Kossiwa; Mahmoudou, Saidou; Kavishna, Ranmali; Nakka, Sravya S.; Rothenberger, Sylvia; Musangomunei, Fungai P.; Olubiyi, Bisola F.; Bie-Ondo, Juste C.; Kabwende, Anita L.; Velavan, Thirumalaisamy P.; Medaglini, Donata; Nakaya, Helder I.; Engler, Olivier; Harandi, Ali M.; Siegrist, Claire-Anne; Kremsner, Peter G.; Agnandji, Selidji T.

Tübinger Autor(en):

Alabi, Ayodele
Velavan, Thirumalaisamy P.
Kremsner, Peter
Agnandji, Selidji Todagbe

Erschienen in:

Journal of Infection (2024), Bd. 89 (4), Article 106237

Verlagsangabe:

London : W B Saunders Co Ltd

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/j.jinf.2024.106237

ISSN:

0163-4453